Lymphoma Clinical Trials

2085 clinical trials for Lymphoma across international registries, including 193 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics — RECRUITING · NA
• Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy — RECRUITING
• Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas — RECRUITING · PHASE2
• Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma — RECRUITING · PHASE1
• Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients — RECRUITING
• AMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE) — RECRUITING
• Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic Lymphoma — RECRUITING · PHASE1
• Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT) — RECRUITING · NA
• Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors — RECRUITING · NA
• RAT-HEMATO : Return to Work After Malignant Hemopathy — RECRUITING · NA
• A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma — RECRUITING · PHASE2
• Sample Collection and Tracking for the Developmental Therapeutics Clinic — RECRUITING
• Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy — RECRUITING · PHASE2
• A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma — RECRUITING · PHASE3
• Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis — RECRUITING
• Vaccine Responses in Patients With B Cell Malignancies — RECRUITING · PHASE4
• Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors — RECRUITING · PHASE1
• Mosaic Trial for Stem Cell Transplant Recipients — RECRUITING · NA
• Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors — RECRUITING · PHASE1
• Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy. — RECRUITING · PHASE2
• A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma — RECRUITING · PHASE2
• Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy — RECRUITING · NA
• Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant — RECRUITING · NA
• The CARDIOPROTECT Trial — RECRUITING · PHASE2
• A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy — RECRUITING · PHASE2
• A Phase 2 Trial of Mosunetuzumab and Zanubrutinib for Patients With Relapsed/Refractory Marginal Zone Lymphoma — RECRUITING · PHASE2
• Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing — RECRUITING
• Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors — RECRUITING · PHASE1
• Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases — RECRUITING · PHASE1
• TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas — RECRUITING · PHASE1
• A Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma — RECRUITING · PHASE2
• A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell Therapy — RECRUITING · PHASE2
• More Than Just X-Rays - Imaging of Chemotherapy-induced Morphological and Functional Cardiovascular and Lung Changes After Childhood ALL and Other Cancers - a Monocentric Late Effects Study (MaximALL) — RECRUITING · NA
• A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21) — RECRUITING · PHASE1
• A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051) — RECRUITING · PHASE1
• Combating Cancer-Related Fatigue: A Personalized Supportive Care Program — RECRUITING · NA
• Registry of Older Patients With Cancer — RECRUITING
• Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders — RECRUITING · PHASE2
• Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event — RECRUITING · NA
• AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies. — RECRUITING · PHASE1
• Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O) — RECRUITING
• A Prospective Clinical Study on Reduced-intensity Radiotherapy for Stage I/II Low-risk Nasal-type NK/T-cell Lymphoma Achieving Complete Remission After Chemotherapy — RECRUITING · PHASE2
• Assessment of the Safety and Efficacy of Balstilimab for the Treatment of Relapsed/Refractory Lymphomas (IMMONC0001) — RECRUITING · PHASE2
• Exercise as an Immune Adjuvant for Allogeneic Cell Therapies — RECRUITING · PHASE1
• Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution — RECRUITING
• Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas — RECRUITING · PHASE1
• Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers — RECRUITING
• An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers — RECRUITING · NA
• Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant — RECRUITING
• Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD) — RECRUITING · PHASE2

Refine this search